X T L Biopharmaceuticals reported $269K in Debt for its fiscal quarter ending in December of 2025.





Debt Change Date
Alaunos Therapeutics USD 10.99M 5.78M Mar/2023
Bioline Rx USD 7.94M 1.13M Jun/2026
Teva Pharmaceutical Industries USD 16.98B 110M Sep/2026
X T L Biopharmaceuticals USD 269K 131K Dec/2025